GPC3127–136-HSP70 mRNA Nanovaccine in Combination with Anti-PD-L1 Therapy Elicits Robust T-Cell-Mediated Immunity against Hepatocellular Carcinoma(KTA2011-5.5)
GPC3127–136-HSP70 mRNA Nanovaccine in Combination with Anti-PD-L1 Therapy Elicits Robust T-Cell-Mediated Immunity against Hepatocellular Carcinoma(KTA2011-5.5)